Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 501–600 of 859
Ji, J., Qian, Q., Cheng, W., Ye, X., Jing, A., Ma, S., Ding, Y., Ma, X., Wang, Y., Sun, Q., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06713-7 · Cited by 24
“The Wnt signaling pathway plays a pivotal role in a myriad of developmental and pathological phenomena, including physical maturation [23], cancer [24], and degenerative conditions [25].”
Pharmacological Inhibition of Protein Lipidation
Ganesan, L., & Levental, I. (2015) · The Journal of Membrane Biology · doi:10.1007/s00232-015-9835-4 · Cited by 20
“pancreatic, colon, and hepatocellular carcinoma (Polakis 2012).”
BackgroundFalcón, T., de Freitas, M. V., Mello, A. C. D. M., Coutinho, L., Álvares‐da‐Silva, M. R., & Matte, Ú. D. S. (2018) · BioMed Research International · doi:10.1155/2018/2864120 · Cited by 19
“This signaling pathway has been associated with malignant transformation [40].”
BackgroundWnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation
Liu, S., Harmston, N., Glaser, T. L., Wong, Y., Zhong, Z., Madan, B., Virshup, D. M., & Petretto, E. G. (2020) · Genome Medicine · doi:10.1186/s13073-020-00788-5 · Cited by 18
“The most common mutations activating Wnt/β-catenin signaling occur in colorectal cancer, where truncations of APC cause abnormal stabilization of -catenin and constitutive transcriptional activation (Polakis, 2012; Zhan et al., 2017; Zhong & Virshup, 2019).”
BackgroundLee, W., & Thévenod, F. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.114 · Cited by 24
“Cooperativity between the Wnt signaling and various other developmental signaling pathways has also been implicated in promoting or even potentiating carcinogenesis, such as NF-kB (see([208]) and below).”
BackgroundInfluentialJinrong, C., Xavier, H. W., Chen, D., Liu, Y., Li, H., & Bian, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690501 · Cited by 20
“Wnt signaling pathway is a highly conserved signaling pathway in eukaryotes and commonly divided into canonical (β-catenin dependent) and non-canonical (β-catenin independent) pathways (Polakis, 2012).”
BackgroundRegulation of metastasis of bladder cancer cells through the WNT signaling pathway
Du, Y., Wang, Y., Zhang, F., Wu, W., Wang, W., Li, H., Xia, S., & Liu, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-3563-3 · Cited by 18
“However, the activation of WNT signaling results in inhibition of the degradation of βcatenin, and the accumulation of β-catenin in the cytosol will lead to its nuclear translocation to activate gene expression that regulates various biological events of the cells [17–20].”
BackgroundRetractedStructure–activity relationship studies of QS11, a small molecule Wnt synergistic agonist
Singh, M. K., Gao, H., Sun, W., Song, Z., Schmalzigaug, R., Premont, R. T., & Zhang, Q. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.062 · Cited by 18
Alizadeh, A., Jebelli, A., Baradaran, B., Amini, M. A., Oroojalian, F., Hashemzaei, M., Mokhtarzadeh, A., & Hamblin, M. R. (2020) · Gene · doi:10.1016/j.gene.2020.145224 · Cited by 18
Zhang, Y., Wu, H., He, R., Ye, C., Chen, H., Wang, J., & Li, Z. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.04.010 · Cited by 19
Personalised Medicine for Colorectal Cancer Using Mechanism-Based Machine Learning Models
Nwaokorie, A., & Fey, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189970 · Cited by 17
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L
Prigaro, B. J., Esquer, H., Zhou, Q., Pike, L. A., Awolade, P., Lai, X.-H., Abraham, A. D., Abbott, J. M., Matter, B. A., Kompella, U. B., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01778 · Cited by 19
Potential roles of the exosome/microRNA axis in breast cancer
Mamalo, A. S., Alivirdiloo, V., Sadeghnejad, A., Hajiabbasi, M., Gargari, M. K., & Valilo, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154845 · Cited by 18
Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review
Guo, S., Zheng, S., Liu, M., & Wang, G. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081024 · Cited by 18
“Abnormal Wnt/ β -catenin signaling has been widely documented in several types of cancers [127–130].”
BackgroundExpression profile and clinical significance of Wnt signaling in human gliomas
Zhang, H., Qi, Y., Geng, D., Shi, Y., Wang, X., Yu, R., & Zhou, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7315 · Cited by 21
Molecular pathogenesis of parathyroid tumours
Cinque, L., Pugliese, F., Salcuni, A. S., Scillitani, A., & Guarnieri, V. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.11.001 · Cited by 17
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
Martinez-Font, E., Pérez-Capó, M., Vögler, O., Martín‐Broto, J., Alemany, R., & Obrador‐Hevia, A. (2021) · Cancers · doi:10.3390/cancers13215521 · Cited by 18
“Interestingly, these RSPO2 and RSPO3 gene fusions are mutually exclusive and occurred in tumors without Cancers 2021, 13, 5521 9 of 30 APC or CTNNB1 mutations [100].”
BackgroundInfluentialKap-β2/Transportin mediates β-catenin nuclear transport in Wnt signaling
Hwang, W. Y., Kostiuk, V., González, D. P., Lusk, C. P., & Khokha, M. K. (2022) · eLife · doi:10.7554/elife.70495 · Cited by 20
Zfp703 Is a Wnt/β-Catenin Feedback Suppressor Targeting the β-Catenin/Tcf1 Complex
Kumar, A., Chalamalasetty, R. B., Kennedy, M. W., Thomas, S., Inala, S. N., Garriock, R. J., & Yamaguchi, T. P. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.01010-15 · Cited by 19
“With the stimulation of signaling, through the presence of Wnt ligand or mutations that activate signaling (20), stabilized -catenin enters the nucleus and binds to Tcf1 (Tcf7), Tcf4 (Tcf7l2), or Lef1.”
BackgroundThe role of Dickkopf family in cancers: from Bench to Bedside.
Shao, Y.-C., Yan, W., Liu, J.-F., & Xu, X. (2017) · Europe PMC (PubMed Central) · Cited by 18
Abou‐Fadel, J., Bhalli, M., Grajeda, B. I., & Zhang, J. (2022) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2021.0221 · Cited by 18
“…has major impacts on regulating development and stemness, and is involved in carcinogenesis in several major cancers, including gastrointestinal (Polakis, 2012; Christie et al. , 2013), leukemia (Luis et al. , 2012; Lento et al. , 2013; Wang et al. , 2014), melanoma (Mir-oliubov and Miroliubov,…”
Biomechanical regulation of planar cell polarity in endothelial cells
Wang, C., Qu, K., Wang, J., Qin, R., Li, B., Qiu, J., & Wang, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166495 · Cited by 18
Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases
Chen, W., Wang, F., Zhang, D.-S., Luo, H., Wang, Z., Wang, F., Qiu, M., Ren, C., Wei, X., Wu, W.-J., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-222 · Cited by 19
“Recent genetic discoveries based on tumor genome sequencing suggest that the Wnt pathway plays important roles in tumor biology [23].”
BackgroundConstruction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling
Jacobsen, A., Heijmans, N., Verkaar, F., Smit, M. J., Heringa, J., van Amerongen, R., & Feenstra, K. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155743 · Cited by 18
Cancer and Biotechnology: A Matchup that Should Never Slowdown
Hrout, A. A., Baig, B., Hilal‐Alnaqbi, A., & Amin, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-53880-8_3 · Cited by 17
Mattu, S., Saliba, C., Sulas, P., Zavattari, P., Perra, A., Kowalik, M. A., Monga, S. P., & Columbano, A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.022 · Cited by 16
Shen, T., Chen, Z., Qiao, J., Sun, X., & Xiao, Q. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0204-4 · Cited by 16
Saxena, M. T., Kalathur, R. K. R., Rubinstein, N., Vettiger, A., Sugiyama, N., Neutzner, M., Coto‐Llerena, M., Kancherla, V., Ercan, C., Piscuoglio, S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2910 · Cited by 16
“Inappropriate activation of theWnt signaling pathway, for example by activating mutations in positively acting components or loss of function of negative regulators of the pathway, has been shown to drive several malignancies including breast cancer (2).”
BackgroundSoldi, R., Ghosh, T., Sampson, S., Vankayalapati, H., Weston, A., Thode, T. G., Bhalla, K. N., Ng, S., del Villar, R. R., Drenner, K., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000634 · Cited by 19
“Mutations in b-catenin or its regulatory factors, such as APC or AXIN2/conductin, result in aberrant activation of the Wnt signaling pathway and are found in a variety of human cancers including breast, colorectal, ovarian, lung, melanoma, prostate, adrenal carcinoma, and leukemias (Clevers and Nusse, 2012; Polakis, 2…”
BackgroundPhysiological and pathological functions of βB2-crystallins in multiple organs: a systematic review
Li, M., Liu, S., Huang, W. C., & Zhang, J. (2021) · Aging · doi:10.18632/aging.203147 · Cited by 16
Luttik, K. P., Tejwani, L., Ju, H., Driessen, T. M., Smeets, C. J. L. M., Edamakanti, C. R., Khan, A., Yun, J., Opal, P., & Lim, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208513119 · Cited by 20
Zhu, L., Chen, Y., Du, H., Cong, Y., Yan, W., Ma, K., & Huang, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.079 · Cited by 18
Lv, S., Zhang, J., He, Y., Liu, Q., Wang, Z., Liu, B., Shi, L., & Wu, Y. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13185 · Cited by 16
Li, Y., Li, X., Qu, J., Luo, D., & Hu, Z. M. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s225556 · Cited by 16
Engineering L7Ae for RNA-Only Delivery Kill Switch Targeting CMS2 Type Colorectal Cancer Cells
Yang, J., & Ding, S. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00612 · Cited by 16
Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma
Ding, Y., & Chen, Q. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1456959 · Cited by 20
Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis
LUO, J., Xu, L., Jiang, Y., Zhuo, D., ZHANG, S., Lian-hui, W., XU, H., & Huang, Y. L. (2016) · Oncology Reports · doi:10.3892/or.2016.4606 · Cited by 16
MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer
Sarwar, A., Wang, B., Su, Q., & Zhang, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114357 · Cited by 16
Kasperek, A., Béguin, A., Bawa, O., de Azevedo, K., Job, B., Massard, C., Scoazec, J., Heidmann, T., & Heidmann, O. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13069 · Cited by 16
Sharma, M., Castro‐Piedras, I., Rodgers, A. D., & Pruitt, K. (2021) · Genes & Cancer · doi:10.18632/genesandcancer.217 · Cited by 14
“Wnt signaling is notoriously hyperactivated in different tumor types such as gastrointestinal cancer, leukemia and breast cancer [3, 15, 18].”
BackgroundSun, X., Fang, J., Ye, F., Zhang, S., Huang, H., Hou, J., & Wang, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.871788 · Cited by 21
“WNT signaling is aberrantly activated in plenty of tumors including lymphoma and contributes to the development of cancer (9, 10).”
BackgroundSchweigert, A., Fischer, C., Mayr, D. C., von Schweinitz, D., Kappler, R., & Hubertus, J. (2016) · Pediatric Surgery International · doi:10.1007/s00383-016-3970-6 · Cited by 19
“APC is the most frequently mutated human gene in cancer [30] and especially crucial in the tumorigenesis of colorectal can-”
BackgroundNUDT7 Loss Promotes KrasG12D CRC Development
Song, J., Park, S., Oh, J., Kim, D., Ryu, J. H., Park, W. C., Baek, I., Cheng, X., Lü, X., & Jin, E. (2020) · Cancers · doi:10.3390/cancers12030576 · Cited by 15
Moubarak, A. A., Joumaa, M. M. E., Slika, L., Patra, D., & Borjac, J. (2021) · BioNanoScience · doi:10.1007/s12668-021-00842-5 · Cited by 15
González-Peña, S. M., Calvo‐Anguiano, G., Villarreal, L., Áncer-Rodríguez, P. R., Lugo-Trampe, J. D. J., Saldívar‐Rodríguez, D., Hernández-Almaguer, M. D., Calzada-Dávila, M., Guerrero-Orjuela, L. S., & Campos-Acevedo, L. D. (2021) · Nutrients · doi:10.3390/nu13062071 · Cited by 15
Liu, C., Yan, Y., Di, F., Li, W., Yin, X., & Dong, L. (2021) · Environmental Toxicology · doi:10.1002/tox.23364 · Cited by 15
Pećina‐Šlaus, N., Kafka, A., Vladušić, T., Tomas, D., Logara, M., Skoko, J., & Hrašćan, R. (2016) · International Journal of Experimental Pathology · doi:10.1111/iep.12186 · Cited by 15
“Among three Wnt signalling cascades, the canonical Wnt signalling pathway is one of the basic mechanisms of cell signalling, controlling events ranging from cell cycle regulation and embryonic cell fate determination to cell motility (MacDonald et al. 2009; Polakis 2012).”
BackgroundKim, W., Shen, H., Jung, D., & Williams, D. R. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9333-1 · Cited by 14
Lithium as a disease-modifying agent for prion diseases
Relaño-Ginés, A., Lehmann, S., Brillaud, E., Bélondrade, M., Casanova, D., Hamela, C., Vincent, C., Poupeau, S., Sarniguet, J., Alvarez, T. J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0209-4 · Cited by 16
Structural and dynamic characterization of human Wnt2-Fzd7 complex using computational approaches
Kalhor, H., Poorebrahim, M., Rahimi, H., Shabani, A. A., Karimipoor, M., Eidgahi, M. R. A., & Teimoori‐Toolabi, L. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3788-3 · Cited by 15
Gene Expression Analysis of Human Papillomavirus‐Associated Colorectal Carcinoma
Qiu, Q., Li, Y., Fan, Z., Yao, F., Shen, W., Sun, J., Yuan, Y., Chen, J., Cai, L., Xie, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/5201587 · Cited by 15
“Deregulations of Wnt/β-catenin signaling were associated with CRC [44, 45].”
BackgroundAn Evolutionary Genetic Perspective on Cancer Biology
Shpak, M., & Lu, J. (2016) · Annual Review of Ecology Evolution and Systematics · doi:10.1146/annurev-ecolsys-121415-032109 · Cited by 20
Hereditary Diffuse Gastric Cancer: A 2022 Update
Kole, C., Charalampakis, N., Sakellariou, S., Papaxoinis, G., Apostolou, K. G., Machairas, N., Papanikolaou, I. S., & Schizas, D. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12122032 · Cited by 20
Fang, C., Zeng, Z., Ye, J., Ni, B., Zou, J., & Zhang, G. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04220-w · Cited by 18
“It is an evolutionarily conserved pathway, typically divided into β-catenin-dependent and independent types [101].”
Kwon, Y., Ye, D.-J., Baek, H., & Chun, Y. (2018) · Environmental Toxicology · doi:10.1002/tox.22560 · Cited by 24
“Wnt/b-catenin signaling is usually activated in cancers by the genetic alteration or epigenetic modulation of key components in the signaling pathway, such as glycogen synthase kinase-3b (GSK-3b) and adenomatous polyposis coli (APC).(60) The activation of Wnt/b-catenin signaling mostly presents the inactivation of GSK…”
BackgroundImproved Prediction of Cancer Outcome Using Graph-Embedded Generative Adversarial Networks
Park, C., Oh, I., Choi, J., Ko, S., & Ahn, J. (2021) · IEEE Access · doi:10.1109/access.2021.3054894 · Cited by 14
“Moreover, aberrant activation of the canonical Wnt signaling pathway can cause uncontrolled cell growth and transformation into malignancy [60].”
BackgroundComputational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines
Wlochowitz, D., Haubrock, M., Arackal, J., Bleckmann, A., Wolff, A., Beißbarth, T., Wingender, E., & Gültaş, M. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00042 · Cited by 17
“Keywords: colorectal cancer, promoter analysis, pathway analysis, master regulator analysis, Wnt pathway”
BackgroundBlundon, M. A., Schlesinger, D. R., Parthasarathy, A., Smith, S. L., Kolev, H. M., Vinson, D. A., Kunttas‐Tatli, E., McCartney, B. M., & Minden, J. S. (2016) · Development · doi:10.1242/dev.130567 · Cited by 15
“INTRODUCTION The canonical Wnt signaling pathway is well conserved in metazoan development, and normal Wnt signaling regulates embryonic patterning by controlling cell fate determination and stem cell behavior (Polakis, 2012; Kozinski and Dobrzyn, 2013).”
BackgroundGillis, W. J., Kirmizitas, A., Iwasaki, Y., Ki, D. H., Wyrick, J. M., & Thomsen, G. H. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0138-x · Cited by 14
“Inappropriate activation of Wnt signaling in ventral tissues during early development can lead to the formation of a secondary axis in a variety of embryos [1, 5], and inappropriate Wnt target gene induction is thought to contribute to a broad range of neoplasms [4, 6, 7] including the majority of hereditary colorecta…”
BackgroundQiao, X., Sun, W., Wang, C., Zhang, L., Li, P., Wen, X., Yang, J., & Yuan, C. (2017) · Molecules · doi:10.3390/molecules22101593 · Cited by 14
Choy, M., Guo, Y., Li, H., Wei, G., Ye, R., Liang, W., Xiao, H., Li, Y., & Guan, H. (2019) · International Journal of Endocrinology · doi:10.1155/2019/7043509 · Cited by 14
Tapia, C., Suares, A., Genaro, P. D., & Pardo, V. G. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104748 · Cited by 14
Keshavarzi, M., Moradbeygi, F., Mobini, K., Ghaffarian‐Bahraman, A., Mohammadi, P., Ghaedi, A., & Mohammadi‐Bardbori, A. (2021) · Toxicology Research · doi:10.1093/toxres/tfab120 · Cited by 15
Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo
Liu, R., Qin, X., Ji, C.-Y., Zeng, W., Yang, Y.-F., & Tan, W. (2015) · Asian journal of urology · doi:10.1016/j.ajur.2015.06.009 · Cited by 13
“Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology [2].”
In silico identification of microRNAs as candidate colorectal cancer biomarkers
Fadaka, A. O., Klein, A., & Pretorius, A. (2019) · Tumor Biology · doi:10.1177/1010428319883721 · Cited by 14
“57,58 The EGFR has been suggested to play a vital role in promoting cell growth.”
BackgroundSHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
Martin, E., & Agazie, Y. M. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0060 · Cited by 14
“Accumulating evidence suggests that dysregulated b-catenin signaling also occurs in TNBC, but themechanism is not clearly understood (12, 13) especially because mutation of APC and other b-catenin destruction complex proteins is rare (14, 15).”
BackgroundMetabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels
Imkeller, K., Ambrosi, G., Klemm, N., Cabezudo, A. C., Henkel, L., Huber, W. K., & Boutros, M. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110874 · Cited by 12
“As such, aberrant activation of the canonical Wnt pathway is the initiating event of the classical model of Wnt-dependent colorectal tumorigenesis (reviewed in Polakis, 2012).”
BackgroundAngiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
Piesche, M., Ho, V. T., Kim, H. T., Nakazaki, Y., Nehil, M., Yaghi, N. K., Kolodin, D., Weiser, J., Altevogt, P., Kiefel, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1956 · Cited by 13
“For example, the recombination signal–binding protein for immunoglobulin kappa J region (RBP-jk) plays a central role in canonical Notch signaling (20), tankyrase 1 and 2 (TNKS1 and TNKS2) contribute to Wnt signaling (21), transforming acidic coiled-coil containing protein 2 (Tacc2) participates in cell-cycle regulati…”
Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway
Chen, K., Gao, Q., Zhang, W., Liu, Z., Cai, J., Liu, Y., Xu, J., Li, J., Yang, Y., & Xu, X. (2014) · Liver International · doi:10.1111/liv.12458 · Cited by 13
“Several important signalling pathways, including Wnt are frequently found to be activated in cancer (27).”
BackgroundGiuliano, A., Swift, R., Arthurs, C., Marote, G., Abramo, F., McKay, J., Thomson, C., Beltrán, M., Millar, M., Priestnall, S. L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161103 · Cited by 18
“There is also evidence of the dysregulation of Wnt signalling proteins in other carcinomas of the breast, prostate, head and neck and penis with an increased expression of proteins involved in the Wnt signalling network [11–13].”
BackgroundLiu, J., Zhang, G., Lv, Y., Zhang, X., Cui, Y., Yang, S., Kong, X., & Yu, Y. (2017) · Tumor Biology · doi:10.1177/1010428317700408 · Cited by 15
Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids
Zhang, T., Hsu, F.-N., Xie, X.-J., Li, X., Liu, M., Gao, X., Pei, X., Liao, Y., Du, W., & Ji, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621048114 · Cited by 18
“Because dysregulated Wnt activities cause abnormal development and cancer in diverse tissues, as well as metabolic diseases in liver and adipocytes (50, 51), there has been considerable interest in developing small molecules that can modulate Wnt signaling.”
BackgroundChattopadhyay, S., Chaklader, M., & Law, S. K. A. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0470-6 · Cited by 13
Penrose, H. M., Heller, S., Cable, C., Nakhoul, H. N., Ungerleider, N. A., Baddoo, M., Pursell, Z. F., Flemington, E. K., Crawford, S. E., & Savkovic, S. D. (2017) · Oncoscience · doi:10.18632/oncoscience.386 · Cited by 14
“Such dysregulation is found with p53, APC, Wnt, KRAS, and PI3K, which consequently favor cellular transformation, proliferation, survival, and subsequent metastasis [8, 9].”
BackgroundBastías-Candia, S., Martínez, M., Zolezzi, J., & Inestrosa, N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00505 · Cited by 10
“Indeed, the Wnt pathway plays a critical role in carcinogenesis and is considered one of the most significant molecular pathways associated with the malignant transformation leading to tumorigenesis (Polakis, 2012).”
BackgroundHansen, S., Nile, A. H., Mehta, S. C., Fuhrmann, J., & Hannoush, R. N. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00500 · Cited by 13
Restoration of WNT4 inhibits cell growth in leukemia-derived cell lines
García‐Castro, B., Álvarez-Zavala, M., Riveros-Magaña, A. R., Ortiz‐Lazareno, P. C., Ratkovich-González, S., Hernández‐Flores, G., Bravo‐Cuéllar, A., Jave‐Suárez, L. F., & Aguilar‐Lemarroy, A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-557 · Cited by 13
“WNT signaling has been implicated in the regulation of oncogenic growth in leukemias of both myeloid and lymphoid lineages [7,8].”
BackgroundWu, Y., Bai, J., HONG, L., LIU, C., Yu, S., YU, G., & Zhang, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4560 · Cited by 16
Wnt3a is a promising target in colorectal cancer
Tufail, M., & Wu, C. (2023) · Medical Oncology · doi:10.1007/s12032-023-01958-2 · Cited by 14
Advances in the development of Wnt/β-catenin signaling inhibitors
Fujita, M., & Demizu, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00749b · Cited by 15
Parafibromin Abnormalities in Ossifying Fibroma
Costa‐Guda, J., Pandya, C., Strahl, M., Taik, P., Sebra, R., Chen, R., Uzilov, A. V., & Arnold, A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab087 · Cited by 12
“Wnt signaling is a well-established regulator of cell proliferation, cell differentiation, stem cell “stemness,” and bone homeostasis; abnormalities in this pathway have been linked to a variety of human tumors and skeletal disease states (reviewed in [26-28]).”
BackgroundA transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells
Dagg, R. A., Zonderland, G., Lombardi, E. P., Rossetti, G. G., Groelly, F. J., Barroso, S. I., Tacconi, E. M., Wright, B., Lockstone, H. E., Aguilera, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25215-0 · Cited by 14
Zhu, Q., Hu, Y., Jiang, W., Ou, Z., Yao, Y., & Zai, H. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.10.004 · Cited by 14
“44,45 Consistently, the activated Wnt/ b -catenin signaling was observed in hepatoblastoma.”
BackgroundKitazawa, M., Hatta, T., Ogawa, K., Fukuda, E., Goshima, N., & Natsume, T. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00305 · Cited by 14
Kafka, A., Karin‐Kujundžić, V., Šerman, L., Bukovac, A., Njirić, N., Jakovčević, A., & Pećina‐Šlaus, N. (2018) · Croatian Medical Journal · doi:10.3325/cmj.2018.59.213 · Cited by 12
Anti-tumor Activity of Propofol: A Focus on MicroRNAs
Ashrafizadeh, M., Ahmadi, Z., Farkhondeh, T., & Samarghandian, S. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666191023100046 · Cited by 12
Zhu, X., Jia, W., Yan, Y., Huang, Y., & Wang, B. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3246 · Cited by 12
WNT/β-catenin pathway activation in hepatocellular carcinoma: a clinical perspective
Chua, M.-S., Ma, L., Wei, W., & So, S. (2014) · Gastrointestinal Cancer: Targets and Therapy · doi:10.2147/gictt.s44256 · Cited by 12
“Deregulations in ligand-independent components of the wNT/β-catenin pathway Mutations in the ligand-independent WNT/β-catenin pathway enhance abnormal accumulation of free β-catenin or enhance the transcriptional activity of β-catenin/TCF4 in the nucleus.(43) For example, inactive truncations of APC occur in more than…”
BackgroundThe Wnt/β-catenin Signaling Pathway in Epithelial Mesenchymal Transition
Menezes, M. E. (2014) · Postdoc Journal · doi:10.14304/surya.jpr.v2n7.1 · Cited by 14
“Dysregulated activation of the Wnt signaling pathway promotes tumor development, EMT and metastasis in a variety of cancers [8, 12-14].”
BackgroundHöving, A. L., Sielemann, K., Greiner, J. F. W., Kaltschmidt, B., Knabbe, C., & Kaltschmidt, C. (2020) · Biology · doi:10.3390/biology9120435 · Cited by 11
Guo, Q., Chu, Y., Li, H., Shi, D., Lin, L., Lan, W., & Wu, D. (2021) · European journal of medical research · doi:10.1186/s40001-021-00567-x · Cited by 14
“Wnt/β-catenin signaling is important in tumor initiation and progression [9, 10].”
BackgroundPu, X., Zheng, D., Lv, T., Zhou, Y., Yang, J., & Jiang, L. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.01.003 · Cited by 12
Ji, Y., Huang, P., Woolfenden, S., & Myers, A. P. (2022) · Clinical and Translational Science · doi:10.1111/cts.13287 · Cited by 11
Poodineh, J., Sirati‐Sabet, M., Rajabibazl, M., Ghasemian, M., & Mohammadi‐Yeganeh, S. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14113 · Cited by 11
“However, there is evidence that aberrant Wnt/β- catenin signaling pathway is sufficient to cause mammary cell transformation, and more than 50% of breast tumors are recognized to have an over- activated Wnt/β- catenin signaling pathway (Polakis, 2012).”
BackgroundHuang, Y., Wang, P., Chen, H., Ding, Y., & Chen, Y. (2015) · Biochemical Journal · doi:10.1042/bj20141143 · Cited by 11
Logical design of an anti‐cancer agent targeting the plant homeodomain in Pygopus2
Ali, F., Yamaguchi, K., Fukuoka, M., Elhelaly, A. E., & Kuwata, K. (2016) · Cancer Science · doi:10.1111/cas.12995 · Cited by 10
Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma
Kafka, A., Tomas, D., Lechpammer, M., Gabud, T., Pažanin, L., & Pećina‐Šlaus, N. (2017) · Disease Markers · doi:10.1155/2017/9253495 · Cited by 11
Ben-Ghedalia-Peled, N., Cohen‐Erez, I., Rapaport, H., & Vago, R. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120208 · Cited by 12
Yun, K., Park, C., Ryu, H. J., Ock, C., Lee, Y. H., Baek, W., Yoon, H. I., Han, Y. D., Kim, S. K., Lee, J., et al. (2022) · Cancers · doi:10.3390/cancers14235975 · Cited by 11
“For instance, alterations in the CTNNB1 and APC genes can lead to activation of the Wnt signaling pathway [29], whereas activating GNAQ mutations can lead to Hippo-independent activation of YAP pathways [30] and cancer progression.”
BackgroundNOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm
Dickson, B. J., Gatie, M. I., Spice, D. M., & Kelly, G. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170812 · Cited by 12
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.